MITA releases dose-related standard

Editorial Staff | | Health Imaging | Practice Management

The Medical Imaging & Technology Alliance (MITA) has released the XR-29 Standard Attributes on CT Equipment Related to Dose Optimization and Management, also known as MITA Smart Dose.

MITA Smart Dose is a standard that includes four key features of CT equipment that enable optimization or management of radiation dose delivery while maintaining high image quality, according to a release from MITA. The four features identified by MITA are:

  • DICOM Dose Structured Reporting—Structured reporting enables recording of post-exam dose information in a standardized electronic format. The information can be included in the patient record, promoting the establishment of diagnostic reference levels, as well as facility dose management and quality assurance.
  • CT Dose Check—Dose notifications and dose alerts warn operators and physicians when dose exceeds stable thresholds.
  • Automatic Exposure Controls—Automated technology can adjust the amount of radiation within prescribed bounds as needed to achieve the desired image quality.
  • Pediatric and adult reference protocols—Pre-loaded parameters on a CT system that can be selected by the operator to complete a particular clinical task, such as capturing an image of the abdomen. 

The XR-29 standard is the fourth dose-related standard to be released by MITA since 2010.

Editorial Staff

Related Content

Newly launched report feature provides patients with a visual aid to their imaging
Center for Devices and Radiological Health hit with federal job cuts
Overview of the regulatory landscape of AI in radiology
Concerns about private equity's growing influence in radiology
'Ad hoc' shifts and radiology 'maestros': How one department addressed its workflow hiccups
Not all lead glasses are created equal

Around the web

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

Cardiovascular Business
Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.